{"title":"氟脱氧葡萄糖的背后:正电子发射断层扫描/计算机断层扫描对氟-18标记pet示踪成像的作用","authors":"G. Rendl, L. Rettenbacher, C. Pirich","doi":"10.1111/j.1617-0830.2008.00126.x","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>F-18 fluorodeoxy-glucose (FDG) is the most widely used tracer in positron emission tomography (PET) imaging in Nuclear Medicine. This review deals with the clinical value of other F-18 labelled PET tracers targeting different biological substrates.</p>\n </div>","PeriodicalId":89151,"journal":{"name":"Imaging decisions (Berlin, Germany)","volume":"12 4","pages":"7-14"},"PeriodicalIF":0.0000,"publicationDate":"2009-03-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1617-0830.2008.00126.x","citationCount":"1","resultStr":"{\"title\":\"Behind Fluorodeoxy-Glucose: the Role of Positron Emission Tomography/Computed Tomography for Fluorine-18 Labelled PET-Tracer Imaging\",\"authors\":\"G. Rendl, L. Rettenbacher, C. Pirich\",\"doi\":\"10.1111/j.1617-0830.2008.00126.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n <p>F-18 fluorodeoxy-glucose (FDG) is the most widely used tracer in positron emission tomography (PET) imaging in Nuclear Medicine. This review deals with the clinical value of other F-18 labelled PET tracers targeting different biological substrates.</p>\\n </div>\",\"PeriodicalId\":89151,\"journal\":{\"name\":\"Imaging decisions (Berlin, Germany)\",\"volume\":\"12 4\",\"pages\":\"7-14\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-03-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1617-0830.2008.00126.x\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Imaging decisions (Berlin, Germany)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/j.1617-0830.2008.00126.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Imaging decisions (Berlin, Germany)","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/j.1617-0830.2008.00126.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Behind Fluorodeoxy-Glucose: the Role of Positron Emission Tomography/Computed Tomography for Fluorine-18 Labelled PET-Tracer Imaging
F-18 fluorodeoxy-glucose (FDG) is the most widely used tracer in positron emission tomography (PET) imaging in Nuclear Medicine. This review deals with the clinical value of other F-18 labelled PET tracers targeting different biological substrates.